BSGM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 09:34):

Stats
Today's Volume	6 868.00
Average Volume	1.21M
Market Cap	14.78M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.330
ATR14	$0.0160 (1.21%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Hrkac Frederick	Buy	500 000	Common Stock
2023-12-28	Hrkac Frederick	Buy	900 000	Restricted Stock Units
2023-12-28	Hrkac Frederick	Buy	600 000	Stock Option (Right to Buy)
2023-11-30	Sieckhaus John	Buy	92 300	Common Stock
2023-11-30	Fleming Gray	Buy	131 900	Common Stock

INSIDER POWER
100.00
Last 95 transactions
Buy: 6 442 688 \| Sell: 40 000

Volume Correlation

Long: -0.16 (neutral)

Short: 0.50 (weak)

Signal:(54.51) Neutral

Biosig Technologies Inc Correlation

10 Most Positive Correlations
ROIV	0.951
RDFN	0.939
CRNC	0.935
NLSP	0.934
ALGN	0.932
EVCM	0.927
LCAA	0.925
ARAY	0.923
FTIV	0.923
PRQR	0.923

10 Most Negative Correlations
GRIN	-0.94
MTEX	-0.924
RIVN	-0.922
ZENV	-0.919
PIII	-0.916
SGLB	-0.911
OP	-0.909
LHDX	-0.903
SNPX	-0.903
NVTSW	-0.902

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biosig Technologies Inc Correlation - Currency/Commodity

-0.03
( neutral )

-0.14
( neutral )

0.00
( neutral )

-0.28
( neutral )

-0.68
( moderate negative )

0.08
( neutral )

Biosig Technologies Inc Financials

Annual	2023
Revenue:	$18 000.00
Gross Profit:	$-343 000 (-1 905.56 %)
EPS:	$-3.95

Q4	2023
Revenue:	$12 000.00
Gross Profit:	$-81 000.00 (-675.00 %)
EPS:	$-0.670

Q3	2023
Revenue:	$1 000.00
Gross Profit:	$-91 000.00 (-9 100.00 %)
EPS:	$-0.610

Q2	2023
Revenue:	$0
Gross Profit:	$-165 000 (0.00 %)
EPS:	$-1.580

Financial Reports:

No articles found.

Biosig Technologies Inc

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.